A 30-year-old man is scheduled for a laparoscopic cholecystectomy for biliary colic. He repos a family history of prolonged paralysis during general anesthesia. Which of the following medications should be avoided during his procedure?
**Question:** A 30-year-old man is scheduled for a laparoscopic cholecystectomy for biliary colic. He reports a family history of prolonged paralysis during general anesthesia. Which of the following medications should be avoided during his procedure?
A. Atracurium
B. Vecuronium
C. Rocuronium
D. Sugammadex
**Correct Answer:** C. Rocuronium
**Core Concept:**
The question is related to the avoidance of neuromuscular blocking agents (NMBA) in patients with a family history of prolonged paralysis under general anesthesia. NMBAs are drugs used to temporarily paralyze the skeletal muscles during surgery, allowing for intubation and protection of the airway. However, their prolonged use can lead to prolonged neuromuscular blockade, which can result in respiratory complications and paralysis.
**Why the Correct Answer is Right:**
Rocuronium is a non-depolarizing neuromuscular blocking agent. Among the provided options, rocuronium is the only NMBA, which makes it the correct answer. In this context, rocuronium is to be avoided in the patient due to his family history of prolonged paralysis during anesthesia.
**Why Each Wrong Option is Incorrect:**
A. Atracurium: Atracurium is a non-depolarizing NMBA, similar to rocuronium. Therefore, it should also be avoided in this patient due to his family history of prolonged paralysis.
B. Vecuronium: Similar to rocuronium, vecuronium is a non-depolarizing NMBA. Avoiding it in the patient with a family history of prolonged paralysis is essential.
D. Sugammadex: Sugammadex is a monoclonal antibody drug used to reverse the effects of rocuronium and vecuronium. It is unrelated to NMBAs and does not address the concern of prolonged paralysis in this patient.
**Clinical Pearls:**
1. The patient's family history of prolonged paralysis during anesthesia suggests a potential hereditary neuromuscular disease, such as myasthenia gravis or Lambert-Eaton syndrome. These conditions are characterized by impaired neuromuscular transmission, which can lead to prolonged paralysis and respiratory complications after exposure to NMBAs like rocuronium and vecuronium.
2. In patients with a history of prolonged paralysis under anesthesia, anesthesia providers should exercise caution when considering the use of NMBAs. Anesthesia management strategies should be tailored to minimize the risk of complications in this high-risk patient population.
3. The patient's surgery will likely be performed under general anesthesia, which typically involves the use of NMBAs for intubation and muscle relaxation during surgery. In this case, the anesthesia provider should choose an alternative anesthetic technique that does not involve NMBAs, such as light sedation combined with regional anesthesia like epidural or spinal anesthesia. This approach can minimize the risk of complications related to NMBA exposure in this high-risk patient.